To evaluate, during the first postoperative year in obese pre-menopausal women, the effects of laparoscopic gastric banding on calcium and vitamin D metabolism, the potential modifications of bone mineral content and bone mineral density, and the risk of development of secondary hyperparathyroidism. SUBJECTS: Thirty-one obese pre-menopausal women aged between 25 and 52 y with a mean body mass index (BMI) of 43.6 kg=m 2 , scheduled for gastric banding were included. Patients with renal, hepatic, metabolic and bone disease were excluded. METHODS: Body composition and bone mineral density (BMD) were measured at baseline, 6 and 12 months after gastric banding using dual-energy X-ray absorptiometry. Serum calcium, phosphate, alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, g-glutamyltransferase, bilirubin, urea, creatinine, uric acid, proteins, parathormone, vitamin D 3 , IGF-1, IGF-BP3 and telopeptide, as well as urinary telopeptide, were measured at baseline and 1, 3, 6, 9 and 12 months after surgery. RESULTS: After 1 y vitamin D3 remained stable and PTH decreased by 12%, but the difference was not significant. Serum telopeptide C increased significantly by 100% (P < 0.001). There was an initial drop of the IGF-BP3 during the first 6 months (P < 0.05), but the reduction was no longer significant after 1 y. The BMD of cortical bone (femoral neck) decreased significantly and showed a trend of a positive correlation with the increase of telopeptides (P < 0.06). The BMD of trabecular bone, at the lumbar spine, increased proportionally to the reduction of hip circumference and of body fat. CONCLUSION: There is no evidence of secondary hyperparathyroidism 1 y after gastric banding. Nevertheless biochemical bone markers show a negative remodelling balance, characterized by an increase of bone resorption. The serum telopeptide seems to be a reliable parameter, not affected by weight loss, to follow up bone turnover after gastroplasty.
Introduction
The prevalence of obesity has markedly increased in the whole world. This increase has been estimated at approximately 60% in Europe 1 during the last 15 y, and 50% in the USA 2 over the last 10 y. The efficacy of conservative therapy for obesity has not improved accordingly. 3 A recent survey showed that, after a successful diet alone, 75% of dieters regained most of the lost weight within 1 y, and 85 -90% regained it after 2 y. 4 Morbid obesity is associated with significant comorbid conditions and a reduced life expectancy. 5, 6 Because of the increasingly recognized fact that conservative therapy for morbid obesity is associated with an almost 100% long-term failure rate, and probably because of the development of laparoscopic surgery, the demand for bariatric surgery is expanding rapidly. Today, malabsorptive procedures and their potentially severe side effects have been replaced by restrictive operations, such as vertical banded gastroplasty, gastric banding and Roux-en-Y gastric bypass. Ideally, these operations should provide a good weight loss with no or only minimal side effects, and no severe long-term metabolic complications.
Malabsorptive procedures such as jejuno-ileal bypass and bilio-pancreatic diversion can cause multiple complications including malnutrition in 21% of the treated patients, anemia in 30% and metabolic bone disease in 73%. 7, 8 The modifications of bone mineral density result from calcium and vitamin D malabsorption, and from secondary hyperparathyroidism. 9 Other factors than vitamin D and calcium deficiency contribute to osteopenia and=or osteoporosis. This is supported by the fact that the fall in serum calcium is not always due to a disturbance of vitamin D metabolism. 10, 11 Roux-en-Y gastric bypass is essentially restrictive, but also causes moderate and selective malabsorption. 12 Several studies have shown a high incidence of vitamin B 12 (70%), folate (38%) and iron (49%) deficiencies, and anemia (12%) after this procedure. 13, 14 Gastric bypass may also be associated with modifications of the bone metabolism due in part to secondary hyperparathyroidism. 15 The latter results from insufficient calcium intake, low calcium absorption due to decreased gastric acidity and reduced surface of absorption, and from increased production of calcium-binding substances in the plasma. 16 -18 A reduction of bone density, but without evidence of hyperparathyroidism, has also been observed after vertical banded gastroplasty, a purely restrictive operation. 19 Laparoscopic gastric banding is now one of the most commonly performed bariatric procedure. It causes a significant reduction of food intake, and thereby a significant weight reduction, especially during the first postoperative year. 20, 21 Because of the major nutritional restriction, there are potential risks of mineral and vitamin deficiencies. 22 Unfortunately, the literature lacks data related to bone metabolism after gastric banding.
The aim of our study was therefore to evaluate, during the first postoperative year, the effects of laparoscopic gastric banding on calcium and vitamin D metabolism, the changes of biological markers of bone remodelling, the risk of development of secondary hyperparathyroidism, and the potential modifications of bone mineral content and bone mineral density.
Methods

Patients
Our patients were evaluated by a multidisciplinary team, including an endocrinologist, a psychiatrist, a dietician, an anaesthesiologist, a pneumologist and a bariatric surgeon. Provided there was a history of obesity for at least several years, and attempts of unsuccessful treatments with diet for at least 2 y, patients were considered for bariatric surgery if their body mass index (BMI) exceeded 40 kg=m 2 (morbid obesity), or if it exceeded 35 kg=m 2 (severe obesity) with at least one comorbidity. Contraindications were essentially of a psychiatric nature (psychosis, drug or alcohol dependence). In order to have a homogeneous group, and because most of our patients are females, only pre-menopausal women were included in this study. Exclusion criteria were pre-existing hepatic, renal, metabolic or bone diseases, or the use of drugs that could influence bone metabolism, such as oral contraceptives.
Surgical procedures
All the patients received one dose of prophylactic perioperative antibiotics, and were given peri-and postoperative lowmolecular-weight heparin. Laparoscopic gastric banding was performed through five operative ports according to a technique that has been described in details elsewhere. 23 A adjustable gastric band (Lap-Band 1 , Bioenterics, Carpinteria, CA, USA) or a Swedish adjustable gastric band (SAGB 1 , Obtech Medical, Zug, Switzerland) was used. The band was left deflated at the end of the operation, and was first adjusted after 1 month. Further adjustments were performed according to weight loss and food tolerance.
Anthropometric measures
Body weight and height were measured with a Detecto scale and stadiometer, and the body mass index (BMI) was calculated as weight (kg) divided by the square of height (m 2 ). Percentage excess body weight (EBW) was calculated as percentage excess of ideal body weight. 24 All body circumferences were taken in a standing position using a TEC anthropometric tape (Rollfix, Hoechst. Mass, Germany). Waist and hip circumferences were measured at the smallest standing horizontal circumference between the ribs and the iliac crest and the largest standing horizontal circumference of the buttocks, respectively. 25 Three measurements were taken at each site with the criterion that the difference between the measurements had to be less than 2 cm. Additional measurements were taken when needed until this criterion was fulfilled.
The anthropometric parameters were measured at baseline, and after 1, 3, 6, 9 and 12 months. Furthermore the total body composition, ie fat body mass and fat free mass, was assessed at baseline and after 6 and 12 months using dual-energy X-ray absorptiometry (DXA; Hologic QDR 2000). 26, 27 Biological parameters Blood samples for measurement of bone markers were collected in the morning after an overnight fast. Serum corrected calcium (total calcium=((total proteins=160) þ 0.55); Ca), phosphate (P), alkaline phosphatase (AP), aspartate aminotransferase (ASAT), alanine aminotransferase (ALAT), g-glutamiltransferase (gGT), bilirubin, urea, creatinine, uric acid and total proteins were measured by the SSCC 37 C method, using an automatic Hitachi 917 Roche, with Roche and BioMérieux kits. Vitamin D 3 was assessed by radioimmunoassay (RIA) with the 125-I-RIA Kit from DiaSorin. The intact parathyroid hormone (PTH) was assessed by immunometric dosage (CIA, Chemiluminescens Immuno Assay; Nichols Institute Diagnostics). Insulin-like growth factor I Bone metabolism after gastric banding N Pugnale et al (IGF-1) and Insulin-like growth factor -binding protein 3 (IGF-BP3) were measured by RIA kits with extraction (Nichols Institute Diagnostic). The urinary telopeptide was measured by CrossLaps TM Elisa assay (Osteometer Biotech A=S, Herlev, Denmark). The serum telopeptide was measured by b-CrossLaps=serum Elecsys test (Roche). All parameters were assessed before and 1, 3, 6, 9 and 12 months postoperatively.
Bone mineral density and bone mineral content Dual-energy X-ray absorptiometry (DXA) was performed before, and 6 and 12 months after surgery. The bone mineral density (BMD) and bone mineral content (BMC) were evaluated at the lumbar spine (L 2 -L 4 ) and the trochanter levels (trabecular bone), and at the femoral neck (cortical bone). Short-term DXA precision error of the lumbar spine and femoral neck is about 0.9 and 1.4%, respectively, in normal subjects. 28, 29 A change of BMD exceeding 3% for individual subjects was considered significant in according to the CV of the Hologic machine used in this study. 30 
Statistical analysis
Means and standard deviation (s.d.) were calculated for age, anthropometric measurements, biological parameters and bone mineral results. Comparison of data before and after gastroplasty was performed by analysis of variance and paired Student's t-test for all variables. Spearman's correlation was used to assess multivariate relationships between anthropometric and biological parameters and bone mineral measurements. Differences were interpreted as statistically significant at P < 0.05. Statistics were performed using the Jmp 3 statistical package (the SAS Institute, Carry, NC).
Results
Anthropometric parameters
Median age was 36 y (range 25 -52, standard deviation 7.2). Baseline and follow-up anthropometric measurements and body composition data are summarized in Table 1 .
We observed a significant mean weight loss of 27.6 AE 9.4 kg (P < 0.001), respectively, of 23.3% of the initial body weight (P < 0.001). Fat body mass decreased by 36.8% (P < 0.001) at 12 months. Waist and hip circumferences decreased significantly by 17.4 and 15.9%, respectively (P < 0.001). The percentage of excess body weight decreased by 59% after 12 months (P < 0.001).
Biological parameters
The results of the biological parameters are summarized in Table 2 . Calcium and phosphate increased moderately, but remained within the normal range. Vitamin D 3 and alkaline phosphatase remained unchanged at 12 months after an initial fall during the first 3 months. PTH decreased slowly, but the 12% difference remained insignificant 1 y after surgery. This reduction correlated with fat loss and body weight (P < 0.05). The urinary telopeptide=urinary creatinine ratio was significantly increased after 12 months (P < 0.05). There was, however, a large intra-individual variability caused by the changes of creatinine excretion linked to the Data are given as mean AE standard deviation; *P < 0.001 assessed from baseline value. Mean AE standard deviation; *P < 0.01; ** P < 0.05, assessed from baseline value.
Bone metabolism after gastric banding N Pugnale et al decrease of the FFM. Serum telopeptide increased significantly over time (Figure 1) , especially during the first 6 months. After 12 months, the mean value was doubled compared with the baseline (P < 0.01). IGF-1 remained stable. There was an initial drop of the IGF-BP3 during the first 6 months (P < 0.05), but the reduction was no longer significant after 1 y.
Bone mineral density and bone mineral content
Modifications of bone mineral content and bone mineral density are summarized in Table 3 . Total BMC and BMD decreased in each patient without exceeding the threshold of the clinically significant change (3%) for individual. The increase of BMD at the lumbar spine, was correlated with changes of body composition. A multivariable analysis Figure 1 Modifications of serum telopeptides and of bone mineral density of femoral neck. Data are given as mean value, and percentage from baseline; *P < 0.01. Bone metabolism after gastric banding N Pugnale et al showed significant correlations with the decrease of hip circumference (P < 0.005), of fat mass (P < 0.05) and of fat free mass (P < 0.05). At the trochanter the major determinant of BMD change appeared, according to stepwise regression control, to be the reduction of the waist circumference (P < 0.02).
Finally, the decrease of the BMD of the femoral neck (cortical bone) showed a positive trend for a correlation with the increase of serum telopeptide C (P < 0.06), and no correlations with changes of body composition. Twelve months after gastric banding, 48% of patients had a significant reduction of BMD of > 3%.
Discussion
Laparoscopic gastric banding causes a significant reduction of food intake, and a hypercatabolic state, especially during the first post-operative months. This results in a significant weight loss.
During the first three post-operative months, we observed a reduction of alkaline phosphatase, without equivalent drop of other hepatic enzymes (ASAT, ALAT, gGT). There was also a significant increase of serum and urinary telopeptide. Urinary telopeptides exhibit more intra-individual variability than serum telopetides, 10 -45% vs 5 -10%. 31 -33 This higher variability of urinary marker is due to greater inaccuracies associated with urine collection. Moreover, use of creatinine, to normalize the values, may increase withinperson variability by up to 36%. 34 The modifications of urinary creatinine are especially important during weight loss, owing to decrease of fat free mass. The large intraindividual variability of urinary telopeptides found in our study confirms the difficulty of utilizing this biological bone marker during major weight loss. However, the precision error (CV) of utilized serum telopeptides was low enough. 35 In the evaluated population the mean CV was 3.7%.
Alkaline phosphatase being a marker of bone formation, and telopeptides a marker of bone resorption, these biological changes characterize a negative remodelling balance of bone turnover: bone formation is decreased, bone resorption is increased, and bone formation cannot counterbalance bone resorption.
Starting from the third post-operative month, alkaline phosphatase slowly returns to initial values, but the serum telopeptides continue to increase. The bone resorption is still increased, but bone formation returns to normal. The remodelling balance is still negative, and remains negative throughout the first postoperative year.
In the present study, the modifications of PTH, vitamin D 3 , as well as of serum calcium and phosphate, are insignificant up to 1 y post-operatively. This situation shows the absence of secondary hyperparathyroidism, as already reported after vertical-banded gastroplasty. 28 These two operations are characterized by the absence of malabsorption and by the conservation of the surface of absorption of calcium at the duodenum. Therefore our results support the hypothesis that the hyperparathyroidism, which is observed after intestinal and gastric bypass, is probably the consequence of duodenal and intestinal malabsorption and not to insufficient calcium and=or vitamin D intake.
In the absence of secondary hyperparathyroidism, the increased bone resorption is difficult to explain. A critical role in the control of bone remodelling is played by local factors produced by bone marrow cells. The insulin-like growth factors affect the synthesis of bone-specific proteins and the proliferation and differentiation of osteoblast precursors. 36, 37 Indeed, reduced serum levels of IGF-BP3 have been found in our patients as well as in large group of patients with idiopathic osteoporosis, 38 -40 but this might explain low bone formation and not increased resorption.
An other factor potentially involved in the bone remodelling is the reduced level of sex steroids usually observed during weight loss and fat mass reduction. Because the menstrual cycle is irregular for several months after surgery, because of the effect of anaesthesia and the rapid weight loss, the sex hormones cannot be reliably measured in the follicular period of cycle. This is illustrated by the preliminary results of serum oestradiol, assessed in the first 10 patients of our study, which showed a large intra-individual variability. Therefore we could not evaluate the sex steroids and their possible correlations with changes in bone turnover.
The modifications of bone mineral density, evaluated by DXA, are different in the lumbar spine, the trochanter and the femoral neck. This is in agreement with the results of Cundy, 19 who showed a reduction of bone density at the hip, but not at lumbar spine, after vertical-banded gastroplasty.
Current evidence indicates that cortical bone and cancellous bone do not change in exactly the same way. A woman can expect to lose 35% of her cortical bone and 50% of her trabecular bone as she ages. 41 This difference depends upon the differences in metabolically active bone surfaces and levels of turnover, and the different environments of the bone cells in cancellous and cortical bone. Cells in cancellous bone are subject to the influence of a variety of osteotropic cytokines, produced by local cells (mesenchymal cells, lymphocytes, macrophages, smooth muscle cells) in the marrow cavity, whereas cells in the cortical bone are more influenced by systemic osteotropic hormones (IGF-1, IGF-BP3, Platelet-Derived Growth Factor, Transforming Growth Factors). 42 The distribution of cancellous and cortical bone varies in the skeleton. In the lumbar spine, cancellous bone comprises more than 66% of the total bone content. The trochanteric area contains about 50% cortical and 50% cancellous bone. In the femoral neck, cortical bone represents 75%. 43 These differences might partially explain our results. Nevertheless, the contemporary increase of the bone density of trabecular bone and of the telopeptides suggests that the measurement of BMD and BMC by dual-energy X-ray absorptiometry during weight loss is not entirely reliable. In fact, several studies have reported limits of the DXA method in evaluating the BMD in obese patients and during weight loss. In 1998, Van Loan et al 44 
) observed that
Bone metabolism after gastric banding N Pugnale et al the variability of BMD is low for depths of 5 -20 cm, but increases significantly when depths exceed 25 cm, as this is the case in severe obesity. Pietrobelli et al 45 found a fat estimation error due to variation in soft tissue hydration. For these reasons measurements of modifications in BMD may be erroneous when subjects undergo significant weight loss. Tothill et al, 46 but also Spector et al, 47 agree in reporting problems with the method used, which could result from the use of a fat distribution model that is not adequate. The lean and fat components can only be determined in areas that contain no bone. Fat around bone appears as negative bone and that increases falsely BMD. Therefore changes in BMC and BMD must be interpreted with caution during weight loss. 48 -49 This hypothesis finds support in the significant correlations, observed in our study, between changes in fat mass distribution (waist and hip circumferences) and changes in lumbar BMD.
In our study, the lack of correlation between changes of bone markers and changes in BMD and BMC at lumbar and trochanteric levels also suggests that the measured changes are influenced by artefacts. Trabecular bone, the main component at these two levels, is probably more prone to wrong estimation than cortical bone, the major component of the femoral neck. Indeed, the decrease in BMD at the femoral neck level is not correlated with changes in body composition, but shows a positive trend with increase of telopeptides, the markers of bone resorption.
Conclusions
Several findings emerged from this study. Despite the fact that the gastric banding results in a significant weight loss, there is no evidence of secondary hyperparathyroidism 1 y after the operation. The biochemical bone markers show a negative remodelling balance, characterized by a reduction of bone formation, and reduced serum levels of IGF-BP3, especially during the first 3 months post-operatively, and an increase of bone resorption. The method of dual-energy Xray absorptiometry presents some pitfalls in the measurement of BMD changes during major weight loss, due to variation in soft tissue hydration and body fat. Finally, a significant decrease of bone mineral density of cortical bone appears 1 y post-operatively.
The serum telopeptide is a reliable parameter for individuals in clinical practice, not affected by weight loss, while the urinary excretion of telopeptide, which is evaluated by its ratio with urinary creatinine, is influenced by the theoretical decrease of the latter during weight loss.
If these data are confirmed on a larger population and on a longer follow up it will be indicated to evaluate the introduction of a preventive treatment with calcium, and=or vitamin D particularly during the first months after operation, in order to decrease bone turnover and bone resorption. 50 
